title: Chlorhexidine: beta-cyclodextrin inhibits yeast growth by extraction of ergosterol.
abstract: Chlorhexidine (Cx) augmented with beta-cyclodextrin (β-cd) inclusion compounds, termed Cx:β-cd complexes, have been developed for use as antiseptic agents. The aim of this study was to examine the interactions of Cx:β-cd complexes, prepared at different molecular ratios, with sterol and yeast membranes. The Minimal Inhibitory Concentration (MIC) against the yeast Candida albicans (C.a.) was determined for each complex; the MICs were found to range from 0.5 to 2 μg/mL. To confirm the MIC data, quantitative analysis of viable cells was performed using trypan blue staining. Mechanistic characterization of the interactions that the Cx:β-cd complexes have with the yeast membrane and assessment of membrane morphology following exposure to Cx:β-cd complexes were performed using Sterol Quantification Method analysis (SQM) and scanning electron microscopy (SEM). SQM revealed that sterol extraction increased with increasing β-cd concentrations (1.71 ×10(3); 1.4 ×10(3); 3.45 ×10(3), and 3.74 ×10(3) CFU for 1:1, 1:2, 1:3, and 1:4, respectively), likely as a consequence of membrane ergosterol solubilization. SEM images demonstrated that cell membrane damage is a visible and significant mechanism that contributes to the antimicrobial effects of Cx:β-cd complexes. Cell disorganization increased significantly as the proportion of β-cyclodextrin present in the complex increased. Morphology of cells exposed to complexes with 1:3 and 1:4 molar ratios of Cx:β-cd were observed to have large aggregates mixed with yeast remains, representing more membrane disruption than that observed in cells treated with Cx alone. In conclusion, nanoaggregates of Cx:β-cd complexes block yeast growth via ergosterol extraction, permeabilizing the membrane by creating cluster-like structures within the cell membrane, possibly due to high amounts of hydrogen bonding.
authors.affiliation: Faculdade de Odontologia, Departamento de Odontologia Restauradora, Universidade Federal de Minas Gerais , Belo Horizonte, MG , Brasil.
authors.forename: K I R
authors.initials: KI
authors.lastname: Teixeira
authors.forename: P V
authors.initials: PV
authors.lastname: Araújo
authors.forename: R D
authors.initials: RD
authors.lastname: Sinisterra
authors.forename: M E
authors.initials: ME
authors.lastname: Cortés
keywords: Chlorhexidine; membrane-drug interactions; β-cyclodextrin
references.citation: Braz J Microbiol. 2009 Jan;40(1):163-9
references.pmid: 24031337
references.citation: Oral Dis. 2001 Mar;7(2):119-22
references.pmid: 11355437
references.citation: Chem Phys Lipids. 2010 Jun;163(6):480-7
references.pmid: 20359468
references.citation: J Membr Biol. 2006;212(1):29-39
references.pmid: 17206515
references.citation: J Pharm Sci. 1992 Jun;81(6):521-3
references.pmid: 1522487
references.citation: Braz J Microbiol. 2010 Oct;41(4):824-31
references.pmid: 24031562
references.citation: Toxicol In Vitro. 2001 Aug-Oct;15(4-5):271-6
references.pmid: 11566548
references.citation: J Biol Chem. 1984 Jan 10;259(1):441-8
references.pmid: 6706945
references.citation: Lancet Infect Dis. 2003 Dec;3(12):772-85
references.pmid: 14652203
references.citation: Annu Rev Microbiol. 1995;49:95-116
references.pmid: 8561481
references.citation: Int J Biol Macromol. 2009 May 1;44(4):320-5
references.pmid: 19428461
references.citation: Trends Microbiol. 2000 May;8(5):200-1
references.pmid: 10785633
references.citation: Biochim Biophys Acta. 1997 Nov 15;1349(2):131-41
references.pmid: 9421186
references.citation: Biophys Chem. 2009 Mar;140(1-3):69-77
references.pmid: 19073357
references.citation: Braz J Microbiol. 2008 Apr;39(2):257-61
references.pmid: 24031212
references.citation: J Clin Microbiol. 1988 Aug;26(8):1437-41
references.pmid: 3049651
references.citation: Toxicol In Vitro. 2008 Mar;22(2):308-17
references.pmid: 17981006
references.citation: Arch Oral Biol. 2007 Jul;52(7):691-6
references.pmid: 17241611
references.citation: Chem Biol Interact. 2006 Dec 15;164(3):167-73
references.pmid: 17098217
references.citation: Toxicol In Vitro. 2007 Aug;21(5):801-8
references.pmid: 17350222
references.citation: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Jan;87(1):44-9
references.pmid: 9927079
references.citation: Life Sci. 1988;43(6):493-502
references.pmid: 2841549
references.citation: Oral Dis. 2001 Jan;7(1):11-7
references.pmid: 11354914
references.citation: Int J Antimicrob Agents. 2008 Mar;31(3):272-6
references.pmid: 18242063
references.citation: J Antimicrob Chemother. 2006 Jan;57(1):94-103
references.pmid: 16291868
references.citation: Arch Oral Biol. 2009 Jun;54(6):588-94
references.pmid: 19249746
references.citation: J Clin Microbiol. 1999 Oct;37(10):3332-7
references.pmid: 10488201
references.citation: Dent Mater. 2003 Nov;19(7):589-96
references.pmid: 12901982
references.citation: J Struct Biol. 2008 Apr;162(1):121-38
references.pmid: 18180166
references.citation: J Biol Chem. 1990 Sep 5;265(25):15110-7
references.pmid: 2394716
references.citation: Phys Rev Lett. 1988 Jun 6;60(23):2398-2401
references.pmid: 10038341
references.citation: Biochemistry. 1996 Jun 18;35(24):8018-24
references.pmid: 8672506
references.citation: Carbohydr Res. 2007 Nov 5;342(15):2286-96
references.pmid: 17618611
references.citation: Int J Pharm. 2008 Apr 16;354(1-2):248-54
references.pmid: 17920796
references.citation: J Biol Chem. 1984 Sep 10;259(17):10823-6
references.pmid: 6469983
references.citation: Chem Phys Lipids. 2008 Feb;151(2):92-102
references.pmid: 18060874